Recent studies have proven that Lmcd1 participates in the development of cardiac hypertrophy.23 Hojayev and his colleagues proved that FHL2 was able to inhibit the pathological proliferation of the heart.28 The above findings reliably indicate that TES is an essential modulatory of cardiac hypertrophy. The gene discussed is FHL2; the disease is cardiac hypertrophy.